JP Stock MarketDetailed Quotes

4893 Noile-Immune Biotech

Watchlist

174
00.00%

20min DelayTrading Nov 26 15:30 JST

7.53BMarket Cap-6385P/E (Static)

Noile-Immune Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

-68.07%2.59M

-49.37%316.82M

-50.23%2.67M

302.8M

3.24M

8.1M

521.24%625.78M

5.37M

3.55%100.73M

Cost of revenue

-81.39%195K

-68.11%2.26M

164K

258K

787K

1.05M

-69.09%7.08M

671.01%22.9M

Gross profit

-66.09%2.39M

-49.16%314.56M

2.51M

302.54M

2.46M

7.05M

694.91%618.71M

-17.47%77.83M

Operating expense

59.76%342.53M

23.52%341.68M

50.33%1.09B

-38.42%282.04M

316.9M

214.4M

276.61M

-14.23%725.05M

457.99M

20.97%845.34M

Selling and administrative expenses

11.32%113.69M

44.35%147.36M

13.58%443.25M

-65.90%131.35M

--107.69M

--102.13M

--102.08M

18.07%390.25M

--385.16M

15.68%330.52M

-General and administrative expense

11.32%113.69M

44.35%147.36M

13.58%443.25M

--131.35M

--107.69M

--102.13M

--102.08M

18.07%390.25M

----

15.68%330.52M

Research and development costs

103.82%228.84M

11.34%194.32M

93.16%646.71M

106.91%150.69M

--209.22M

--112.28M

--174.52M

-34.97%334.8M

--72.83M

24.64%514.83M

Operating profit

-61.61%-342.53M

-25.87%-339.28M

-629.13%-775.39M

39.19%-279.53M

-14.36M

-211.94M

-269.56M

86.14%-106.35M

-459.7M

-26.97%-767.51M

Net non-operating interest income (expenses)

49K

27.27%28K

-20.00%44K

22K

-31.25%55K

-97.94%80K

Non-operating interest income

--49K

27.27%28K

-20.00%44K

--0

--22K

--0

--22K

-31.25%55K

--0

-97.94%80K

Net investment income

88.75%-160K

-139.04%-310K

-99.91%5K

-88.02%550K

83K

-1.42M

794K

5.48M

4.59M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

Less:Write off

----

--0

Other non-operating income (expenses)

-24.30%-352.25M

-2.02M

-125.19M

-225.05M

-1,025.32%-283.39M

-265.81M

-613.20%-25.18M

Income before tax

-1.21%-342.64M

31.23%-339.57M

-193.49%-1.13B

33.41%-278.98M

-16.27M

-338.55M

-493.79M

51.53%-384.2M

-418.94M

-25.62%-792.62M

Income tax

0.00%605K

0.16%609K

0.00%2.42M

0.00%599K

608K

605K

608K

0.00%2.42M

599K

-57.36%2.42M

Net income

-1.20%-343.24M

31.19%-340.18M

-192.28%-1.13B

33.36%-279.58M

-16.88M

-339.16M

-494.4M

51.37%-386.62M

-419.54M

-24.88%-795.04M

Net income continuous operations

-1.20%-343.24M

31.19%-340.18M

-192.28%-1.13B

33.36%-279.58M

---16.88M

---339.16M

---494.4M

51.37%-386.62M

---419.54M

-24.88%-795.04M

Noncontrolling interests

Net income attributable to the company

-1.20%-343.24M

31.19%-340.18M

-192.28%-1.13B

33.36%-279.58M

-16.88M

-339.16M

-494.4M

51.37%-386.62M

-419.54M

-24.88%-795.04M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-1.20%-343.24M

31.19%-340.18M

-192.28%-1.13B

33.36%-279.58M

-16.88M

-339.16M

-494.4M

51.37%-386.62M

-419.54M

-24.88%-795.04M

Gross dividend payment

Basic earnings per share

7.14%-7.93

37.07%-7.86

-176.06%-27.25

39.76%-6.44

0.22

-8.54

-12.49

48.95%-9.8709

-10.6899

-24.88%-19.3347

Diluted earnings per share

7.14%-7.93

37.07%-7.86

-176.06%-27.25

39.57%-6.4603

-0.39

-8.54

-12.49

48.95%-9.8709

-10.6899

-24.88%-19.3347

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	0	-68.07%2.59M	-49.37%316.82M	-50.23%2.67M	302.8M	3.24M	8.1M	521.24%625.78M	5.37M	3.55%100.73M
Cost of revenue	0	-81.39%195K	-68.11%2.26M	164K	258K	787K	1.05M	-69.09%7.08M		671.01%22.9M
Gross profit	0	-66.09%2.39M	-49.16%314.56M	2.51M	302.54M	2.46M	7.05M	694.91%618.71M		-17.47%77.83M
Operating expense	59.76%342.53M	23.52%341.68M	50.33%1.09B	-38.42%282.04M	316.9M	214.4M	276.61M	-14.23%725.05M	457.99M	20.97%845.34M
Selling and administrative expenses	11.32%113.69M	44.35%147.36M	13.58%443.25M	-65.90%131.35M	--107.69M	--102.13M	--102.08M	18.07%390.25M	--385.16M	15.68%330.52M
-General and administrative expense	11.32%113.69M	44.35%147.36M	13.58%443.25M	--131.35M	--107.69M	--102.13M	--102.08M	18.07%390.25M	----	15.68%330.52M
Research and development costs	103.82%228.84M	11.34%194.32M	93.16%646.71M	106.91%150.69M	--209.22M	--112.28M	--174.52M	-34.97%334.8M	--72.83M	24.64%514.83M
Operating profit	-61.61%-342.53M	-25.87%-339.28M	-629.13%-775.39M	39.19%-279.53M	-14.36M	-211.94M	-269.56M	86.14%-106.35M	-459.7M	-26.97%-767.51M
Net non-operating interest income (expenses)	49K	27.27%28K	-20.00%44K	0	22K	0	22K	-31.25%55K	0	-97.94%80K
Non-operating interest income	--49K	27.27%28K	-20.00%44K	--0	--22K	--0	--22K	-31.25%55K	--0	-97.94%80K
Net investment income	88.75%-160K	-139.04%-310K	-99.91%5K	-88.02%550K	83K	-1.42M	794K	5.48M	4.59M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)										0
Less:Write off	----	----	----	----	----	----	----	----	----	--0
Other non-operating income (expenses)			-24.30%-352.25M	0	-2.02M	-125.19M	-225.05M	-1,025.32%-283.39M	-265.81M	-613.20%-25.18M
Income before tax	-1.21%-342.64M	31.23%-339.57M	-193.49%-1.13B	33.41%-278.98M	-16.27M	-338.55M	-493.79M	51.53%-384.2M	-418.94M	-25.62%-792.62M
Income tax	0.00%605K	0.16%609K	0.00%2.42M	0.00%599K	608K	605K	608K	0.00%2.42M	599K	-57.36%2.42M
Net income	-1.20%-343.24M	31.19%-340.18M	-192.28%-1.13B	33.36%-279.58M	-16.88M	-339.16M	-494.4M	51.37%-386.62M	-419.54M	-24.88%-795.04M
Net income continuous operations	-1.20%-343.24M	31.19%-340.18M	-192.28%-1.13B	33.36%-279.58M	---16.88M	---339.16M	---494.4M	51.37%-386.62M	---419.54M	-24.88%-795.04M
Noncontrolling interests
Net income attributable to the company	-1.20%-343.24M	31.19%-340.18M	-192.28%-1.13B	33.36%-279.58M	-16.88M	-339.16M	-494.4M	51.37%-386.62M	-419.54M	-24.88%-795.04M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-1.20%-343.24M	31.19%-340.18M	-192.28%-1.13B	33.36%-279.58M	-16.88M	-339.16M	-494.4M	51.37%-386.62M	-419.54M	-24.88%-795.04M
Gross dividend payment
Basic earnings per share	7.14%-7.93	37.07%-7.86	-176.06%-27.25	39.76%-6.44	0.22	-8.54	-12.49	48.95%-9.8709	-10.6899	-24.88%-19.3347
Diluted earnings per share	7.14%-7.93	37.07%-7.86	-176.06%-27.25	39.57%-6.4603	-0.39	-8.54	-12.49	48.95%-9.8709	-10.6899	-24.88%-19.3347
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data